InMed Pharmaceuticals ("InMed") was founded in 2014 and is based in Vancouver, British Columbia. The company has three primary areas of focus: 1) developing cannabinoid-based pharmaceuticals, 2) manufacturing cannabinoids through biosynthesis, 3) discovering treatments through bioinformatics.

You must subscribe to Cannabis Investor’s Report Lifetime to view this content.

To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.